United States · FDA National Drug Code directory
Aleve Caplets
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85237-1832_55ba2a2e-a689-621b-e063-6294a90af1b2
- Product NDC
- 85237-1832
- Form
- TABLET
- Composition / generic term
- NAPROXEN SODIUM
- Labeler
- Select Consumer Group
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230404
- Source listing expiry
- 20271231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 POUCH in 1 BLISTER PACK (85237-1832-1) / 1 TABLET in 1 POUCH (85237-1832-0) · 85237-1832-1
- 2 POUCH in 1 BLISTER PACK (85237-1832-2) / 1 TABLET in 1 POUCH · 85237-1832-2
- 25 POUCH in 1 BOX, UNIT-DOSE (85237-1832-4) / 1 TABLET in 1 POUCH · 85237-1832-4
- 50 POUCH in 1 BOX, UNIT-DOSE (85237-1832-6) / 1 TABLET in 1 POUCH · 85237-1832-6
- 3 POUCH in 1 BLISTER PACK (85237-1832-7) / 1 TABLET in 1 POUCH (85237-1832-0) · 85237-1832-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →